Results 51 to 60 of about 14,661,551 (240)
Molecular Oncology, EarlyView.We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source
Journal of Infrastructure Preservation and ResilienceRock salt brine deicers are among the most prevalent solutions for ensuring safe vehicle operation in snow-prone regions. The efficiency of this solution, however, decreases at extremely low temperatures as it is diluted by melted ice.
Gage Merke, Maedeh Hesami, Ravi Kiran
doaj +1 more source
Molecular Oncology, EarlyView.The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Prepairing LiF:Mg,Ti Dosimeter Pellets by Melting Method and Study of Stimulated Response Reduction Function for High Dose Dosimetry [PDF]
مجله علوم و فنون هستهای, 2018 Thermoluminescence dosimeters are widely used for dosimetry in different radiation fields. In this study, the feasibility of the application of the cold-pressed sintered LiF:Mg,Ti dosimeter pellets, produced by the melting method in our TL laboratory ...
F Torkzadeh, F Mardashti
doaj
Reduction of energy consumption and GHGs emission in investment casting process by application of a new casting method [PDF]
, 2012 In conventional investment casting process of aluminium alloys for the application of the aerospace industry, to assure the quality of the final casting, usually the foundry uses large runner system which results in low yield, high energy consumption and
Jolly, Mark R. +5 more
core +1 more source
Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer
Molecular Oncology, EarlyView.Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola +11 more
wiley +1 more source
Molecular Oncology, EarlyView.The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Metalurgija, 2019 The article discusses the filtration method of cleaning silicon, the possibility of mechanical separation of inclusions, the effect of capillary phenomena, the wettability of the filter material on the efficiency of cleaning silicon from impurities ...
A. V. Yurchenko +5 more
doaj
CEACAM1 participation in breast cancer progression
Molecular Oncology, EarlyView.In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Molecular Oncology, EarlyView.Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source